Through Beigene, Amgen helps awaken the sleeping giant; $2.7B cash investment Nov. 4, 2019 By Lee Landenberger and Elise Mak No Comments When the time was right to make a powerful Western biotech welcome in China, Beigene Ltd. was ready when Amgen Inc. came calling. Its massive $2.7 billion cash equity investment in Beigene buys Amgen an oncology footprint in China.Read More